All

Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
25 March 2024

Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline

Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing.

Read the press release
BlueTech Inalve announces the closing of a €4.7 million financing round
25 March 2024

BlueTech Inalve announces the closing of a €4.7 million financing round

The participation of the Blue Forward FundTM, managed by Seventure Partners, and the PSIM fund, managed by Bpifrance on behalf of the French government, confirms the strong...

Read the press release
Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
15 March 2024

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development

The company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and Khosla Ventures, reflects enthusiasm for Siolta's...

Read more
SumUp taps €285M more in growth funding to weather the fintech storm
11 December 2023

SumUp taps €285M more in growth funding to weather the fintech storm

SumUp — the fintech that provides payments and related services to some 4 million small businesses in Europe, the Americas and Australia — has picked up some growth funding...

Read more
Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.
26 October 2023

Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.

Maat Pharma announces that the DSMB unanimoulsy recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host Disease...

Read the press release
SumUp secures $100m credit facility to expand merchant cash advance product
9 August 2023

SumUp secures $100m credit facility to expand merchant cash advance product

The company says its latest offering, SumUp Cash Advance, will help merchants in the UK finance their operations by furnishing advances of up to £20,000 based on their payment...

Read more
IDnow receives ANSSI’s security approval for PVID certification for its identity proofing services IDCheck.io and VideoIdent
1 August 2023

IDnow receives ANSSI’s security approval for PVID certification for its identity proofing services IDCheck.io and VideoIdent

IDnow, a leading identity proofing platform provider in Europe, has obtained the remote identity verification certification known as PVID (prestataire de verification...

Read more
Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
30 June 2023

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

Enterome today announces that the first patient was dosed in the Phase 1/2 'AUDREY' trial evaluating EO4010, the Company's third OncoMimics™ candidate, for the treatment of...

Read the press release
Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma
14 June 2023

Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma

Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry...

Read the press release